Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Uterine Cervical Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

Endometrial Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Advanced Cervical Cancer

Ovarian Neoplasms

Genital Diseases, Neoplasms, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Neoplasm Metastasis, Uterine Neoplasms, Endometrial Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Neoplasms, Endometrial Neoplasms

Ovarian Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms

Uterine Cervical Neoplasms

Endometrial Neoplasms

Low Grade Serous Ovarian Cancer

Locally Advanced Cervical Cancer

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Ovarian Neoplasms

Endometrial Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaccinia

Ovarian Neoplasms

Ovarian Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Recurrence, Endometrial Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Cervical Cancer Metastatic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Neoplasms, Endometrial Neoplasms

Endometrial Neoplasms

Endometrial Neoplasms

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial

Clinical Trials

A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

ASPENOVA

A Study of SHR-A1811 in Subjects With Ovarian Cancer

A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)

TroFuse-020

TroFuse-033

FRAmework-01

TroFuse-036

ROSY-O

DUoENDE

TroFuse-022

MAESTRA 2

TroFuse-021

A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

ENGOT-EN5

OVATION-3

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

DE-01

RAINFOL-04

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

TroFuse-005

RAMP 301

eVOLVECervical

FLORA-5

Avelumab Program Rollover Study

Fern-EC-01

MK-3475-775

A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer

Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01)

A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

KEYNOTE-B96

DO-01

RAINFOL-02

RAINFOL-03

MONO-OLA1

innovaTV 301

GLORIOSA

KEYNOTE-A18

A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment

KEYNOTE-826

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

LEAP-001

XPORT-EC-042

FLAMES

TREVI-OC-01